Phoenix, AZ 的 前列腺癌 臨床試驗
17 項針對 前列腺癌 的研究正在 Phoenix（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
招募中1/2 期
- GSK Investigational Site, Phoenix
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中觀察性研究歡迎健康志工
- Cancer Center at Saint Joseph's, Phoenix
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Mayo Clinic Hospital in Arizona, Phoenix
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Phoenix
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Phoenix
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
招募中3 期
- Mayo Clinic- Phoenix, Phoenix
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, Phoenix
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Cancer Center at Saint Joseph's, Phoenix
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Mayo Clinic, Phoenix
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- Mayo Clinic, Phoenix
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
招募中2 期
- Mayo Clinic in Arizona, Phoenix
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Cancer Center at Saint Joseph's, Phoenix
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Mayo Clinic, Phoenix
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- Cancer Center at Saint Joseph's, Phoenix
Understanding of Genetics by Men at Risk for Prostate Cancer
招募中歡迎健康志工
- Mayo Clinic, Phoenix
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
招募中3 期
- Cancer Center at Saint Joseph's, Phoenix
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN43 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Phoenix 的其他研究
- 乳癌25 項研究
- 大腸直腸癌25 項研究
- 肥胖症22 項研究
- 轉移性癌症20 項研究
- 非小細胞肺癌20 項研究
- 心臟衰竭18 項研究
- 癌症（所有類型）17 項研究
- 心血管疾病16 項研究
- 多發性骨髓瘤16 項研究
- 胰臟癌16 項研究
- 過重15 項研究
- 阿茲海默症15 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。